Fig. 5From: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapyIGG-3 specifically binds to native oligomers and fibrillar a-Syn in vitro. a Slot blot showing the immunoreactivity of a-Syn strains to IGG-3. b Semi-quantitative analysis of the binding of IGG-3 to monomers, oligomers and fibrils. c Slot blot showing the immunoreactivity of a-Syn strains to Syn1. d Semi-quantitative analysis of the binding of Syn1 to monomers, oligomers and fibrilsBack to article page